NCT06472583View on ClinicalTrials.gov

Preoperative Immunotherapy Combined With Stereotactic Radiation Therapy Boost in the Treatment of HER2-negative Breast Cancer

PHASE2RecruitingINTERVENTIONAL
Enrollment

78

Participants

Timeline

Start Date

April 11, 2024

Primary Completion Date

February 28, 2028

Study Completion Date

February 28, 2028

Conditions
Breast Cancer
Interventions
DRUG

Keytruda

Preoperative immunotherapy (200 mg, infusion every 21 days, 4 administrations planned)

RADIATION

Preoperative radiation therapy

Boost of preoperative robotic stereotactic radiotherapy

DRUG

Placebo

0,9% NaCl in the volume 100 ml

Trial Locations (1)

Unknown

RECRUITING

Maria Sklodowska-Curie National Research Institute of Oncology , Gliwice Branch, Gliwice

All Listed Sponsors
lead

Maria Sklodowska-Curie National Research Institute of Oncology

OTHER